CIBC World Market’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$309K Buy
+3,942
New +$269K ﹤0.01% 1352
2025
Q4
Sell
-3,367
Closed -$247K 1490
2025
Q3
$247K Sell
3,367
-3,764
-53% -$250K ﹤0.01% 1293
2025
Q2
$371K Sell
7,131
-67,939
-91% -$3.87M ﹤0.01% 1122
2025
Q1
$4.79M Buy
+75,070
New +$4.36M 0.01% 498
2023
Q1
Sell
-27,214
Closed -$1.55M 1288
2022
Q4
$1.55M Buy
+27,214
New +$1.39M 0.01% 645
2021
Q1
Sell
-110,828
Closed -$4.73M 1343
2020
Q4
$4.73M Buy
+110,828
New +$3.98M 0.02% 375

Other funds holding HALO

CIBC World Market's HALO Position: Q2 2026 in Review

CIBC World Market opened a new position in Halozyme (HALO) in Q2 2026: 3,942 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #1352 among its holdings. This is a return to the name: CIBC World Market previously reported a position in HALO as recently as Q3 2025.

CIBC World Market first reported a position in HALO in Q4 2020 and has held it in 6 quarters since. The position peaked at $4.79M in Q1 2025. 528 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • CIBC World Market held 3,942 shares of Halozyme worth $309K as of Q2 2026.
  • Halozyme was a new CIBC World Market position in Q2 2026.
  • Halozyme made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1352 holding.
  • CIBC World Market first reported a position in Halozyme in Q4 2020 and has held it in 6 quarters since.
  • CIBC World Market's Halozyme position peaked at $4.79M in Q1 2025.
  • 528 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.